RIM targeting of Bmi1 is largely a feature of B-cell lymphomas in the mouse [7], while Notch targeting predominates in the CD4+CD8+ lymphomas of Mmtv(d)-Myc mice [56]. Here, CD8A is linked to B-cell non-Hodgkin lymphoma.